Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates

Beta Bionics, Inc. (BBNX) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.52 per share a year ago.